$2.39
▲ +7.2% Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
Overview
52-week range
$1.52
$25
4% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+18.5%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-1.80 | — | — | -309.1% | +25.5% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-2.82 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.35 | — | — | — | — | financials |
| Fri Aug 15, 2025 | Jun/2025 | $-0.37 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.44 | — | — | — | +11.5% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-4.96 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.70 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.43 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-2.07 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-12.48 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-68.67 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-5.56 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-1.62 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $896,774 | $1M | — | $728,867 | $607,494 | $872,287 | — |
| Cost of revenue | $525,421 | $437,035 | $593,506 | — | $387,499 | $384,381 | $525,486 | — |
| Gross profit | $535,381 | $459,739 | $518,291 | — | $341,368 | $223,113 | $346,801 | — |
| Operating income | $-3M | $-3M | $-3M | — | $-3M | $-2M | $-3M | — |
| Net income | $-3M | $-3M | $-3M | — | $-3M | $-2M | $-3M | — |
| EPS (diluted) | $-1.80 | $-2.82 | $-0.35 | — | $-4.41 | $-4.96 | $-0.70 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $740,371 | $2M | $1M | $3M | $2M | $4M | $6M |
| Inventory | $597,469 | $590,246 | $628,177 | $635,215 | $683,488 | $701,280 | $738,789 | $777,537 |
| Total current assets | $10M | $12M | $4M | $4M | $5M | $4M | $6M | $9M |
| Total assets | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $7M | $7M | $5M | $5M | $4M | $6M | $6M |
| Total equity | $9M | $11M | $3M | $3M | $5M | $4M | $6M | $8M |
Implied volatility — last 90 days
No IV snapshots yet for INBS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.